Related Experiment Video
Updated: Aug 6, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Risk of respiratory distress syndrome as determined by amniotic fluid lecithin concentration
Lecithin concentration has been determined in 476 samples of amniotic fluid collected within 72 hours of delivery. If delivery is associated with a level of lecithin of 0.100 mg/100 ml. of lecithin phosphorus or greater, the risk of RDS in the neonate is minimal, if any. If delivery is associated with a level of lecithin less than 0.100 mg/100 ml. of lecithin phosphorus, a definite risk of RDS is present. This "risk factor" is a function of the lecithin concentraion and may be expressed in terms of a simple mathematical equation. The equation, log y equals minus 1.0187 minus 0.0101 chi, expresses the relationship in a highly significant manner (r equals 0.99) where y equals lecithin concentration and chi equals risk of RDS. In managing individual high-risk patients, our general policy is to weigh the chemically determined "risk factor" of RDS if delivery is done against the clinically determined "risk factors" involved if delivery is delayed. By comparing the various risks involved, appropriate management is decided upon.
Lecithin concentration has been determined in 476 samples of amniotic fluid collected within 72 hours of delivery. If delivery is associated with a level of lecithin of 0.100 mg/100 ml. of lecithin phosphorus or greater, the risk of RDS in the neonate is minimal, if any. If delivery is associated with a level of lecithin less than 0.100 mg/100 ml. of lecithin phosphorus, a definite risk of RDS is present. This "risk factor" is a function of the lecithin concentraion and may be expressed in terms of a simple mathematical equation. The equation, log y equals minus 1.0187 minus 0.0101 chi, expresses the relationship in a highly significant manner (r equals 0.99) where y equals lecithin concentration and chi equals risk of RDS. In managing individual high-risk patients, our general policy is to weigh the chemically determined "risk factor" of RDS if delivery is done against the clinically determined "risk factors" involved if delivery is delayed. By comparing the various risks involved, appropriate management is decided upon.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025